Yingke Capital is a professional equity investment institution.
Business Model:
Revenue: $0
Employees: 0-0
Address: -
City: Shanghai
State: shanghai municipality
Zip: -
Country: CN
Yingke Capital is a principal investment firm specializing in pre-IPO investments. It seeks to invest in 5G internet of things, biomedical, environmental and facilities services, new energy, consumer upgrade, smart manufacturing and materials sector. Yingke Capital prefers to invest in companies with high technology R&a;D and production capacity. Mingfei Qian founded it in 2010, with its headquarters in Fuzhou in China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2021 | Simcere Pharma | Series B | 0 |
11/2022 | Dreamworld AR | Seed Round | - |
12/2021 | Greatpower Technology | Series C | - |
11/2021 | Tonyshare Electronic Materials Technology | Venture Round | - |
8/2021 | JOINN Biologics | Series B | 150M |
12/2022 | Chengmandian Energy Technology | Series A | 14.2M |
9/2017 | Yondervision | Post-IPO Equity | 5.3M |
6/2020 | Asieris Pharmaceuticals | Series C | 41M |
4/2019 | Voc Acoustic Technology | Series A | - |
12/2021 | UnionTech 3D | Series D | 0 |
3/2022 | Chinagene Tech | Series A | 15.8M |
12/2019 | EOC Pharma Group | Series C | 71M |
4/2022 | Changrong Electric | Private Equity Round | - |
3/2022 | Gene Vector | Seed Round | 3.2M |
2/2019 | Haihe Biopharma | Series B | 0 |
8/2018 | Royole Corporation | Series E | - |
8/2020 | Hanyu Medical | Series D | 0 |
1/2022 | Cloudbreak Therapeutics | Series C | 0 |
8/2021 | Berry Oncology | Series B | 99.2M |
8/2020 | Adlai Nortye | Series C | 0 |
3/2016 | Zelgen | Series A | - |
4/2018 | JHOME | Post-IPO Equity | 19.1M |
8/2021 | Beijing Health Guard Biotechnology | Private Equity Round | 156.5M |
1/2016 | SMO ClinPlus | Venture Round | 1M |
6/2018 | LEADTHING | Post-IPO Equity | 11.2M |
9/2017 | Sanyou Medical | Private Equity Round | 15.4M |
7/2018 | Kanghua Biotechnology | Angel Round | - |
12/2021 | Shanghai Union Technology | Series D | 0 |
10/2018 | Chunmi Technology | Series C | 20M |
11/2017 | 11ziyun.com | Post-IPO Equity | 0 |
3/2018 | JAKI | Post-IPO Equity | 16.9M |
12/2020 | Denovo Biopharma | Series D | 0 |
12/2020 | MicuRx Pharmaceuticals | Series E | 106.9M |
1/2018 | 34learning | Seed Round | 468.3k |
2/2017 | Bright Key | Series A | 7.5M |
12/2022 | Huizhou Yipeng Energy Technology Co., Ltd. | Series C | 25.9M |
12/2020 | Microread | Series C | - |
8/2022 | Fourier | Series C | - |
5/2019 | Phylion Battery | Private Equity Round | 136.9M |
8/2018 | Huizhou Yipeng Energy Technology Co., Ltd. | Corporate Round | - |
11/2017 | Goldpro | Corporate Round | 22.7M |
10/2017 | LC Securities | Series B | 3M |
8/2022 | Sunwoda Electric Vehicle Battery | Series A | 884.8M |
8/2021 | Tage I-driver | Series B | 15.5M |
9/2020 | Qihe Biotech | Venture Round | - |
12/2018 | Hanyu Medical | Series B | 14.5M |
8/2018 | Health Engine | Corporate Round | 12.4M |
11/2019 | THOK LOGISTICS | Venture Round | 7.1M |
6/2021 | Dingdang Kuaiyao | Private Equity Round | 0 |
12/2021 | Chengmandian Energy Technology | Seed Round | 0 |
12/2021 | Aoxion Technology | Series A | - |
9/2020 | WM Motor | Series D | 0 |
1/2019 | Heng Yi Biotechnology | Venture Round | 3M |
4/2022 | Changrong Electric | Private Equity Round | - |
3/2022 | Chinagene Tech | Series A | 0 |
3/2022 | Gene Vector | Seed Round | 0 |
1/2022 | Cloudbreak Therapeutics | Series C | 0 |
12/2021 | Chengmandian Energy Technology | Seed Round | 0 |
12/2021 | Aoxion Technology | Series A | - |
12/2021 | UnionTech 3D | Series D | 0 |
12/2021 | Shanghai Union Technology | Series D | 0 |
12/2021 | Greatpower Technology | Series C | - |
11/2021 | Tonyshare Electronic Materials Technology | Venture Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|